PREDICT-EV; the Association of Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK. 90% of strokes are preventable, leading to national focus on programmes including The National Stroke Programme to act on preventing, treating, and improving post-stroke care. Importantly, over 25% of ischaemic stroke sufferers have previously had a Transient Ischaemic Attack (TIA), which presents the biggest concern for TIA patients. There are no measures which reliably identify TIA patients most likely to suffer a stroke. Novel biomarkers for predicting stroke are key to addressing this problem. The PREDICT-EV study aims to screen 300 TIA patients and follow them over 12-months. The investigators will determine if a novel biomarker we've identified to increase thrombotic risk (endothelial derived extracellular vesicles) and the resulting increased prothrombin time is associated with patients at highest risk of stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Patients with or without diagnosis of TIA made by a physician working in stroke medicine, sufficiently so to start post-TIA care or so that no further investigation is thought necessary to confirm or refute the diagnosis.

• TIA confirmed patient has been prescribed antiplatelet drugs or anticoagulants.

• Patients must be aged \> 18 years.

• Patients are taking an ordinary diet by mouth.

• Radiological evidence, on CT and/or MR imaging of the brain of cerebral infarction, with or without secondary haemorrhage.

• The underlying mechanism of cerebral infarction is embolic from a cardiac source (e.g. atrial fibrillation), atherothromboembolic (from aorta or other large vessels in the neck) or in-situ thrombosis. No further investigations are thought necessary to confirm or refute the diagnosis.

• No further investigations are thought necessary to confirm or refute the diagnosis.

• Patients must be aged \>18 years.

• Patients must not be pregnant or breast feeding.

• Patients are taking an ordinary diet by mouth. Exclusion Criteria

Locations
Other Locations
United Kingdom
Prince Charles Hospital
RECRUITING
Merthyr Tydfil
Contact Information
Primary
Jessica Williams, PhD
jwilliams3@cardiffmet.ac.uk
02920417077
Time Frame
Start Date: 2021-10-01
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 360
Treatments
Healthy Control
A group of participants with no previous symptoms or diagnosis of TIA or stroke.
Non-TIA Control
A group of participants who were referred to TIA clinic with symptoms of a TIA, however, were subsequently confirmed as not suffering with a TIA.
TIA, non-stroke
A group of participants who were confirmed as suffering a TIA by a stroke clinician following admission to hospital, admission to Accident and Emergency or after being referred to TIA clinic. These participants did not suffer a stroke within 12 months of TIA diagnosis.
TIA, stroke
A group of participants who were confirmed as suffering a TIA by a stroke clinician following admission to hospital, admission to Accident and Emergency or after being referred to TIA clinic. These participants went on to suffer a stroke within 12 months of TIA diagnosis.
Related Therapeutic Areas
Sponsors
Leads: Cwm Taf University Health Board (NHS)
Collaborators: Cardiff Metropolitan University

This content was sourced from clinicaltrials.gov